Innsbruck University Hospital

Innsbruck A6020

1 studies enrolling now · 8 studies all time

What they study most

Adult, Advanced Solid Tumors, Chronic Graft-versus-host-disease, Chronic Myeloid Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Gastrointestinal (GI) Malignancies, Marginal Zone Lymphoma, Metastatic Cholangiocarcinoma, Myelodysplastic Syndromes, Out-of-hospital Cardiac Arrest, Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Studies at this site

• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• Study of INCA 0186 in Subjects With Advanced Solid Tumors — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
• Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest — Completed
• Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes — Status unconfirmed
• Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) — Completed
• Patient Reported Outcomes in Chronic Myeloid Leukemia — Completed